These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8397255)

  • 41. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
    Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
    Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma.
    Du Bois JS; Trehu EG; Mier JW; Shapiro L; Epstein M; Klempner M; Dinarello C; Kappler K; Ronayne L; Rand W; Atkins MB
    J Clin Oncol; 1997 Mar; 15(3):1052-62. PubMed ID: 9060545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.
    Tilg H; Trehu E; Atkins MB; Dinarello CA; Mier JW
    Blood; 1994 Jan; 83(1):113-8. PubMed ID: 8274730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of circulating IL-1 receptor antagonist by IFN treatment.
    Tilg H; Mier JW; Vogel W; Aulitzky WE; Wiedermann CJ; Vannier E; Huber C; Dinarello CA
    J Immunol; 1993 May; 150(10):4687-92. PubMed ID: 8482853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.
    Tilg H; Trehu E; Shapiro L; Pape D; Atkins MB; Dinarello CA; Mier JW
    Cytokine; 1994 Mar; 6(2):215-9. PubMed ID: 8032003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapy.
    Tilg H; Pape D; Trehu E; Shapiro L; Atkins MB; Dinarello CA; Mier JW
    J Immunol Methods; 1993 Aug; 163(2):253-8. PubMed ID: 8354894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
    Miles DW; Aderka D; Engelmann H; Wallach D; Balkwill FR
    Br J Cancer; 1992 Dec; 66(6):1195-9. PubMed ID: 1333789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: role of plasma and polymyxin B.
    Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Pereira BJ
    Int J Artif Organs; 1996 May; 19(5):276-83. PubMed ID: 8791147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.
    Voss SD; Hank JA; Nobis CA; Fisch P; Sosman JA; Sondel PM
    Cancer Immunol Immunother; 1989; 29(4):261-9. PubMed ID: 2787694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of immune response during immunotherapy.
    Panelli MC; Nagorsen D; Wang E; Monsurro V; Jin P; Katia Z; Smith K; Ngalame Y; Marincola FM
    Yonsei Med J; 2004 Jun; 45 Suppl():15-7. PubMed ID: 15250044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.
    Marie C; Fitting C; Cheval C; Losser MR; Carlet J; Payen D; Foster K; Cavaillon JM
    Infect Immun; 1997 Mar; 65(3):865-71. PubMed ID: 9038289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.
    de Winter RJ; Manten A; de Jong YP; Adams R; van Deventer SJ; Lie KI
    Heart; 1997 Dec; 78(6):598-602. PubMed ID: 9470879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red Blood Cells Store and Release Interleukin-33.
    Wei J; Zhao J; Schrott V; Zhang Y; Gladwin M; Bullock G; Zhao Y
    J Investig Med; 2015 Aug; 63(6):806-10. PubMed ID: 26107423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
    Wagner SC; Markosian B; Ajili N; Dolan BR; Kim AJ; Alexandrescu DT; Dasanu CA; Minev B; Koropatnick J; Marincola FM; Riordan NH
    J Transl Med; 2014 May; 12():127. PubMed ID: 24884532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theabrownin from Pu-erh tea together with swinging exercise synergistically ameliorates obesity and insulin resistance in rats.
    Wu E; Zhang T; Tan C; Peng C; Chisti Y; Wang Q; Gong J
    Eur J Nutr; 2020 Aug; 59(5):1937-1950. PubMed ID: 31273522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicities of Immunotherapy for the Practitioner.
    Weber JS; Yang JC; Atkins MB; Disis ML
    J Clin Oncol; 2015 Jun; 33(18):2092-9. PubMed ID: 25918278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring of immunotherapy with cytokines or monoclonal antibodies.
    Erik Hack C
    Cytotechnology; 1995 Jan; 18(1-2):93-106. PubMed ID: 22358641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Red cell antigens: Structure and function.
    Pourazar A
    Asian J Transfus Sci; 2007 Jan; 1(1):24-32. PubMed ID: 21938229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.